Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease
Open Access
- 2 October 2012
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 79 (14) , 1499-1506
Abstract
Objective: To assess the available evidence for the diagnostic accuracy of CSF testing for protein 14-3-3 in patients with suspected sporadic Creutzfeldt-Jakob disease (sCJD). Methods: The authors performed a systematic review of the available literature from 1995 to January 1, 2011, to identify articles involving patients who were suspected of having sCJD and who had CSF analysis for protein 14-3-3. Studies were rated according to the American Academy of Neurology classification of evidence scheme for diagnostic studies, and recommendations were linked to the strength of the evidence. A pooled estimate of sensitivity and specificity was obtained for all studies rated Class II or higher. The question asked is “Does CSF 14-3-3 protein accurately identify Creutzfeldt-Jakob disease (CJD) in patients with sCJD?” Results: The analysis was conducted on the basis of samples of 1,849 patients with suspected sCJD from 9 Class II studies. Assays for CSF 14-3-3 protein are probably moderately accurate in diagnosing sCJD: sensitivity 92% (95% confidence interval [CI] 89.8–93.6), specificity 80% (95% CI 77.4–83.0), likelihood ratio of 4.7, and negative likelihood ratio of 0.10. Recommendation: For patients who have rapidly progressive dementia and are strongly suspected of having sCJD and for whom diagnosis remains uncertain (pretest probability ∼20%–90%), clinicians should order CSF 14-3-3 assays to reduce the uncertainty of the diagnosis (Level B).Keywords
This publication has 33 references indexed in Scilit:
- Rapidly progressive dementiaAnnals of Neurology, 2008
- Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob diseaseBrain, 2006
- 14-3-3 -isoform detection distinguishes sporadic Creutzfeldt-Jakob disease from other dementiasJournal of Neurology, Neurosurgery & Psychiatry, 2005
- A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Coexistence of 21-Hydroxylase and 11β-Hydroxylase Deficiency in Adrenal Incidentalomas and in Subclinical Cushing’s SyndromeHormone Research in Paediatrics, 2002
- 14-3-3 Proteins: Structure, Function, and RegulationAnnual Review of Pharmacology and Toxicology, 2000
- Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob diseaseAnnals of Neurology, 1998
- The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform EncephalopathiesNew England Journal of Medicine, 1996
- 14-3-3 Proteins: Hot numbers in signal transductionCurrent Biology, 1995
- Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clusteringAnnals of Neurology, 1979